TrkB as well as BDNF have been reported to be overexpressed in various types of cancer, such as colorectal and cervical cancers, and BDNF/TrkB overexpression has been shown to confer a migratory phenotype and chemotherapy resistance to tumor cells [12]. The gene discussed is NTRK2; the disease is neoplasm.